EMISPHERE ACHIEVES SECOND MILESTONE IN ROCHE COLLABORATION
Emisphere Technologies, Inc. announced today that it has achieved a second milestone
under its November 2004 agreement with Roche to develop new oral formulations
of a Roche small molecule compound for the treatment of bone-related diseases.
The achievement of this milestone, resulting in an undisclosed payment from
Roche, arises from Roche's initiation of a clinical study utilizing Emisphere's
eligen(R) delivery technology in a formulation for a second product.